ASRS 2025: Dry AMD
Warren Pan, MD, PhD Kellogg Eye Center, Ann Arbor, MI The Dry AMD Session 3 at ASRS 2025 showcased groundbreaking clinical trials for geographic atrophy (GA) secondary to AMD, featuring novel therapies targeting complement…
Category: AMD
ARVO 2025: Proctor Medal Award Dr. Cynthia Owsley & Dr. Christine Curcio
Timothy T. Xu, MD Mayo Clinic, Rochester, MN Dr. Cynthia Owsley and Dr. Christine Curcio were honored with the ARVO 2025 Proctor Medal Award for their contributions to earlier detection…
VBS 2025: Rapid Fire Medical Retina
Tianyu Liu, MD Associated Retinal Consultants, Royal Oak, MI Jeffrey Yu, MD Kellogg Eye Center, University of Michigan, Ann Arbor, MI Dr. Glenn Jaffe moderated a lively discussion with panelists…
Angiogenesis 2025 – High Resolution OCT and Trial Results in AMD and DME using Migaldendranib
Spencer Barrett, MD Bascom Palmer Eye Institute, Miami, FL Novel Findings from High Res OCT Talk (Dr. Freund) Dr. K. Bailey Freund presented a talk on “Novel Findings from Innovative…
Angiogenesis 2025 – Results of the SALWEEN trial and Differential for Macular Atrophy
Michael Massengill, MD Bascom Palmer Eye Institute, Miami, FL Dr. Giovanni Staurenghi delivered an insightful presentation on the Differential Diagnosis of Macular Atrophy. He emphasized the importance of distinguishing age-related…
Angiogenesis 2025 – Results of the Golden and Verona Studies
Joseph Pecha, MD, MPH Bascom Palmer Eye Institute, Miami, FL Efficacy and Safety of Complement Factor B Antisense, IONIS-FB-LRx, in Geographic Atrophy due to Age-Related Macular Degeneration: Results of the…
AAO 2024: Debates on Complement Therapy, FA, Pneumatic Retinopexy, RD Repair Timing, Floaters
Olufemi Adams, MD and Michael Yu, MD Wills Eye Hospital, Philadelphia, PA During this year’s Debates at Retina Subspecialty Day, experts sparred over medical and surgical retina topics ranging from…
AAO 2024: Late Breaking Abstracts
Chloe Y. Li, MD Columbia University/New York Presbyterian, New York City, NY Clinical trial results dominated this year’s Late-Breaking Abstracts session at Retina Subspecialty Day, featuring new results from trials…